tiprankstipranks
H.C. Wainwright still sees opportunity for Neumora despite trial miss
PremiumThe FlyH.C. Wainwright still sees opportunity for Neumora despite trial miss
16d ago
Tesla reports below-consensus deliveries: Morning Buzz
Premium
The Fly
Tesla reports below-consensus deliveries: Morning Buzz
16d ago
RBC downgrades Neumora Therapeutics to Sector Perform after trial failure
Premium
The Fly
RBC downgrades Neumora Therapeutics to Sector Perform after trial failure
16d ago
Morning Movers: Neumora Therapeutics plummets after KOASTAL-1 misses endpoint
PremiumThe FlyMorning Movers: Neumora Therapeutics plummets after KOASTAL-1 misses endpoint
16d ago
Neumora down 82%  after saying navacaprant did not meet primary endpoint
Premium
The Fly
Neumora down 82% after saying navacaprant did not meet primary endpoint
16d ago
Neumora Therapeutics’ navacaprant did not meet primary endpoint in depression
Premium
The Fly
Neumora Therapeutics’ navacaprant did not meet primary endpoint in depression
16d ago
J&J trial news may have positive read for Neumora Therapeutics, says RBC Capital
PremiumThe FlyJ&J trial news may have positive read for Neumora Therapeutics, says RBC Capital
1M ago
Neumora Therapeutics Reports Q3 2024 Financial Results
Premium
Company Announcements
Neumora Therapeutics Reports Q3 2024 Financial Results
2M ago
Neumora Therapeutics reports Q3 EPS (45c), consensus (39c)
Premium
The Fly
Neumora Therapeutics reports Q3 EPS (45c), consensus (39c)
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100